These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 332684)

  • 21. Transmissible drug resistance in human and animal trains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Adetosoye AI
    Res Vet Sci; 1980 Nov; 29(3):342-5. PubMed ID: 6789419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaerobic R factor transfer in Escherichia coli.
    Moodie HL; Woods DR
    J Gen Microbiol; 1973 Jun; 76(2):437-40. PubMed ID: 4579134
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of Hfr DNA from Escherichia coli merozygotes during inhibition of conjugation by nalidixic acid.
    Lloyd RG; Hart J; Johnson S
    Genet Res; 1980 Aug; 36(1):69-79. PubMed ID: 7002729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibiotic sensitivity of gram-negative bacilli isolated from lesions since 1965].
    Yamaji Y; Takahashi M; Miyanaga Y; Todome Y; Motoyama M
    Jpn J Antibiot; 1968 Feb; 21(1):25-33. PubMed ID: 4174373
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Simplified method for conjugational transference of R factors on solid culture media].
    Tiagunenko IuV
    Antibiotiki; 1971 Feb; 16(2):158-62. PubMed ID: 4934036
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of R-factors on the sensitivity of Shigella sonnei to nalidixic acid].
    Sivolodskii EP
    Antibiotiki; 1976 Dec; 21(12):1085-9. PubMed ID: 798548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid measurement of bacterial sensitivity to ampicillin and nalidixic acid.
    Chadwick P
    Can Med Assoc J; 1967 Sep; 97(14):846-51. PubMed ID: 4963759
    [No Abstract]   [Full Text] [Related]  

  • 31. Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Nishida M; Mine Y; Matsubara T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1972 Oct; 25(10):582-93. PubMed ID: 4567453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gentamicin sensitivity of bacteria isolated from clinical materials].
    Ozawa A; Mori T; Goto J
    Jpn J Antibiot; 1971 Jun; 24(3):126-9. PubMed ID: 4935009
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
    Piekarska K; Rzeczkowska M; Zacharczuk K; Chróst A; Januszkiewicz A; Bareja E; Olak M; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(3):211-9. PubMed ID: 23285775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
    Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of enterobacteriaceae and nonfermenting gram-negative bacilli.
    Washington JA
    Mayo Clin Proc; 1969 Nov; 44(11):811-24. PubMed ID: 4310745
    [No Abstract]   [Full Text] [Related]  

  • 36. Competition between strains of Escherichia coli with and without plasmid RP4 during chemostat growth.
    Numan Z; Venables WA; Wimpenny JW
    Can J Microbiol; 1991 Jul; 37(7):509-12. PubMed ID: 1913355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transferable resistance to gentamicin. I. Expression of the resistance character].
    Witchitz JL; Chabbert YA
    Ann Inst Pasteur (Paris); 1971 Dec; 121(6):733-42. PubMed ID: 4948138
    [No Abstract]   [Full Text] [Related]  

  • 38. [R-factor transmission in E. coli: a function of the growth phase of donor cells].
    Bergmann D; Wiedemann B
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):303-7. PubMed ID: 4145836
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of penicillin and nalidixic acid on growth and cell division of Escherichia coli K-12.
    Hrebenda J; Hrebenda B; Brzostek K
    Acta Microbiol Pol; 1985; 34(1):19-24. PubMed ID: 2579523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
    Mouton RP; Koelman A
    Chemotherapy; 1966; 11(1):10-26. PubMed ID: 4959585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.